ReviewMolecules (Basel, Switzerland)2024
Catalytic Reduction of Aromatic Nitro Compounds to Phenylhydroxylamine and Its Derivatives.
Review in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Monosubstituted N-Arylhydroxylamine Chemistry: Integrating Contemporary Synthetic Approaches for the Efficient Construction of Diverse Heterocyclic Scaffolds.Chemistry (Weinheim an der Bergstrasse, Germany) · 2026Review
- Preparation of a Near-infrared Probe Based on Triphenylamine Thiophene and its Use for the Fluorescence Imaging of HJournal of fluorescence · 2026Article
- Biocatalytic reduction of nitro-sulfonamides: enzyme engineering, process integration, and sustainable pathways toFrontiers in bioengineering and biotechnology · 2026Review
- Crystallographic and Electroanalytical Analyses of Fexinidazole and Its Major Metabolites.ACS omega · 2025Article
- The psychostimulant drug, fenethylline (captagon): Health risks, addiction and the global impact of illicit trade.Drug and alcohol dependence reports · 2025Review
- Photocatalytic reduction of nitro compounds using TiOPhotochemistry and photobiologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Phenylhydroxylamine and its derivates (PHAs) are important chemical intermediates. Phenylhydroxylamines are mainly produced via the catalytic reduction of aromatic nitro compounds. However, this catalytic reduction method prefers to generate thermodynamically stable aromatic amine. Thus, designing suitable catalytic systems, especially catalysts to selectively convert aromatic nitro compounds to PHAs, has received increasing attention but remains challenging. In this review, we initially provide a brief overview of the various strategies employed for the synthesis of PHAs, focusing on reducing aromatic nitro compounds. Subsequently, an in-depth analysis is presented on the catalytic reduction process, encompassing discussions on catalysts, reductants, hydrogen sources, and a comprehensive assessment of the merits and drawbacks of various catalytic systems. Furthermore, a concise overview is provided regarding the progress made in comprehending the mechanisms involved in this process of catalytic reduction of aromatic nitro compounds. Finally, the main challenges and prospects in PHAs' production via catalytic reduction are outlined.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.